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Once an individual is diagnosed to have diabetes a number oJ events usually Jollow and 
the patient usually finds himself reJerred to the Diabetic clinic at the Diabetic outpatients 
department at St Luke's Hospital. This setting has been developed over the years and it is 
aimed to offer specialised management to diabetic patients by diabetologists. 
Many diabetic patients are also cared for, by their own Family doctor 
in the private setting. Whoever the care giver is, the most important 
factor is that continuity of care and patient support are ensured. This can 
be a problem without a patient registration system, where the patient-
doctor relationship is lacking. Patient education and support for self 
management is of paramount importance in complex chronic diseases 
such as diabetes. There needs to be good liaison between the various 
health care specialists when dealing with diabetic complications, such as 
the ophthalmologist, vascular surgeon, dietician and podologist. 
Assessment of newly diagnosed patient 
History 
1. Duration of symptoms e.g. thirst, polyuria, weight loss 
2. Possible secondary causes of diabetes e.g. acromegaly 
3. Family history 
4. Concurrent complications of diabetes 
5. Presence of risk factors e.g . smoking, hyperlipidaemia , 
hypertension. 
Examination 
1. Body mass index (BM!) 
2. Cardiovascular system ( BP and peripheral pulses) 
3. Signs of peripheral and autonomic neuropathy 
4. Eyes to exclude retinopathy 
Investigations 
The relevance and type of investigations calTied out will depend on 
the outcome of history and examination but should include the 
following: 
I. Blood tests for creatinine, urea and electrolytes, a full lipid profile 
and thyroid and liver function tests 
2. Utine tcsts for ketones and albuminuria(macro and micro) 
3. AnECG 
Current recommendations for glycaemic control 
The Amelican Diabetes Association currently recommends an 
HbAI e level of less than 7 percent fOt· all diabetic patients to decrease 
the tisk of long term micrm'ascular complications l . Le\'C1s stipulated b), 
the Intemational Diabetes Federation are similar though somewhat more 
sOingent as can be seen from Table I (on the right). 
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These recommendations were adopted from the research protocols of 
landmark studies1. Both bodies acknowledge that blood glucose level targets 
should be individually detelmined and based on the individual patient's 
charactetistics, including the patient's tisk of hypoglycaemia, ability to sense 
hypoglycaemic symptoms, as well as the concurrent eo-morbidities such 
as cardiovascular disease and seizure problems. 
The Alc reflects glycaemic control in the previous 90 days, but is more 
weighted by the most recent values. The glycaemia control within the last 
30 days connibutes about 50% of the Alc value, while 90 to 120 days 
before the test connibute 10% to the final value of the Alc.; 
Preparation for Ale Testing Self-monitoting of blood glucose (SMBG) 
done several times a day for one to t"vo weeks before an A I c test greatly 
improves the effectiveness of a periodic consultation. 
What is significant change, in a patient's blood 
glucose parameters? 
If a patient's register entry for HAlc reads 6.7% and 7.5% six months apart, 
does it mean there has been Significant deterioration? The answer to this 
1able 1. Recommendations for glycaemic control 
HbAle Preprandial BG Post Prandial BG 
ADA <7.0% <5 .0-7.2mmol/1 < 1O.Ommol/1 
IDF <6.5% <6 .0mmol/1 <8.0mmol/1 
1able 2. Correlation between Alc Level and Mean Plasma Glucose Levels3 
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question will have meaning in any auditing exercise about the outcome of 
any intervention, be it dietary or exercise modification advice or treatment 
regimens. The question above really has t\vo questions: 
l. Is change statistically significant or is it an error due to intra 
patient variability with laboratory results? 
2. Is the change clinically Significant? i.e. does it translate into a 
change in patient clinical outcomes? 
To answer the first question one has to de termine the overall 
variability of HbAlc estimation method and biological variability. For 
Ale estimations the coefficient of variation C1TT is about 6%. The fommla 
to estimate the least Significant change (LSC) in a set confidence interval 
z (C!) is: LSe= zY2xOTT 
One thus has to set a confidence level at which one is to decide 
that any change is real and not just "noise". Thus to be 80% confident 
(z= l.28) that change between two readings is real , the LSC = 
U8x 1414 x 6 = 10.9%. Now change in this scenario is [75/67-
l]xlOO%= 11.94% which is greater than the LSC calculated above. Thus 
the change in HbAl c can be considered Significant with 80% confidence 
(hence 20% false alarm possibility) . 
Having determined that the change in Al c is statistically significant, 
we can now attempt to answer the second question, whether the change 
has clinical sequelae. The DCCTl and UKPD9 studies provide us with 
data relating change in Alc \vith clinical outcomes. In a patient with 
type2 diabetes a 1%detCll0mtiol1 ill Ale is expected to IrJlect a 30% advme 
microvascular lish inaeasc. Thus risk of retinopathy (a complication from 
microvascular disease) is increased by 24% if HbAl c deteriorates by an 
absolute increase of 0.8% (ie. 67% to 75%) 
This knowledge \vill make the patient and his caring team focus 
more on the need to achieve an HbAlc less than 65% once more to 
minimise the dreaded long term complications. 
Self.monitoring of blood glucose 
Recommendations for the use of self moni toring of blood glucose 
(SMBG) in type 1 diabetes are expliCit while in the case of type 2 are 
less so, particularly because it was thought that type 2 patients were 
less likely to suffer from life threatening hypos and hyperglycaemias . 
However 5MB G is a tool that can help type 2 diabe tic patients 
understand and gain control of their disease and more patients should 
be encouraged to use this tool in clinical practice. 
Evidence based recommendations of 5MBG 
The recommendation of 5MBG for patients who have type 1 
diabetes are based on the results obtained from the DCCT (Diabetes 
Control and Complications Trial) 2 which evaluated the relationship 
bet\Veen Ale levels and rates of complications. The test times (fasting, 
preprandial and night-time) were chosen to minimise the lisk of 
hypoglycaemia and a two-hour post prandial test was chosen if the 
patient did not achieve the pre-set HbAlc target. To date literature 
review did not encounter any RCT comparing the outcomes of 
different tes ting regimens. 
In U1e case of type 2 diabetics, the optimum frequency for 5MBG is 
simply "not known") Recent reviews of RCTs on the evidence ofSMBG 
in type 2 diabetes found a few trials which had inconsistent resultsb 
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Interpretation of blood glucose values 
It is evident that the blood glucose levels taken at any point in time, 
contribute to the overall glycaemiC control, however for practical 
reasons it is important to standardise times at which blood glucose 
readings are more useful. It comes lvith no surprise the fact that 
if preprandial glucose is high post prandial levels will definitely 
be higher. Post prandial testing has the important limitation of 
intrapersonal variability associated with the type of food ingested. 
The glycaemic index (GI) of different foods reflects the differing 
carbohydrate composition of foods which \vill give different blood 
glucose levels due to their rate of digestion and absorption. The Gl 
is calculated by comparing the particular food lvith a standard food 
(white bread which is given a value 100) The GI principle relies a 
lot on scientific precision which is not realistic. A better working 
modification is the glyacemic load (GL) which is calculated as: {GI 
x carbohydrate (g) }/l00. Thus whereas a food may have a high GI, 
if one eats very little of it, the GL will be small. A proposed method 
for achieving BG control is to 
1. Get the fasting BG on target 
2. Get the BG before evening meal on target 
3. Check HbAlc. If not on target check for periods of high blood 
glucose during the rest of the day or even at night. 
Thus the three most relevant BG readings 
should be: 
l. Fasting, 2. before lunch, 3. before dinner (and if uncontrolled 
2 hours after dinner) 
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